Skip to content
Trial Eligibility
Menu

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

NCT04855825

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Multiple Sclerosis
  • Gait Disorders, Neurologic
  • Motility Disorder
  • Cognitive Impairment

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 75 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Kessler Foundation
Last updated on ClinicalTrials.gov
November 24, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New Jersey · 1

  • Kessler Foundation · West Orange, NJ

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.